Nanobiotix S.A. (0QAV.L)

EUR 3.48

(1.75%)

Net Income Summary of Nanobiotix S.A.

Nanobiotix S.A.'s latest annual net income in 2023 was -39.7 Million EUR , up 30.4% from previous year.
Nanobiotix S.A.'s latest quarterly net income in 2024 Q2 was -21.87 Million EUR , down 0.0% from previous quarter.
Nanobiotix S.A. reported an annual net income of -57.04 Million EUR in 2022, down -21.36% from previous year.
Nanobiotix S.A. reported an annual net income of -47 Million EUR in 2021, down -39.93% from previous year.
Nanobiotix S.A. reported a quarterly net income of -28.09 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Nanobiotix S.A. reported a quarterly net income of -11.6 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of Nanobiotix S.A. (2023 - 2012)

Historical Annual Net Income of Nanobiotix S.A. (2023 - 2012)

Year	Net Income	Net Income Growth
2023	-39.7 Million EUR	30.4%
2022	-57.04 Million EUR	-21.36%
2021	-47 Million EUR	-39.93%
2020	-33.59 Million EUR	34.03%
2019	-50.91 Million EUR	-67.79%
2018	-30.34 Million EUR	-16.07%
2017	-26.14 Million EUR	-19.48%
2016	-21.88 Million EUR	-28.69%
2015	-17 Million EUR	-77.92%
2014	-9.55 Million EUR	-17.33%
2013	-8.14 Million EUR	-52.79%
2012	-5.33 Million EUR	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-21.87 Million EUR	0.0%
2023 Q2	-28.09 Million EUR	0.0%
2023 Q4	-11.6 Million EUR	0.0%
2023 FY	-39.7 Million EUR	30.4%
2022 Q4	-30.68 Million EUR	0.0%
2022 FY	-57.04 Million EUR	-21.36%
2022 Q2	-26.35 Million EUR	0.0%
2021 Q4	-16.58 Million EUR	0.0%
2021 Q2	-30.42 Million EUR	0.0%
2021 FY	-47 Million EUR	-39.93%
2020 FY	-33.59 Million EUR	34.03%
2020 Q2	-20.57 Million EUR	0.0%
2020 Q4	-13.01 Million EUR	0.0%
2019 Q4	-26.99 Million EUR	0.0%
2019 Q2	-23.92 Million EUR	0.0%
2019 FY	-50.91 Million EUR	-67.79%
2018 FY	-30.34 Million EUR	-16.07%
2018 Q4	-17.73 Million EUR	0.0%
2018 Q2	-12.61 Million EUR	0.0%
2017 Q2	-12.18 Million EUR	0.0%
2017 FY	-26.14 Million EUR	-19.48%
2017 Q4	-13.95 Million EUR	0.0%
2016 Q2	-10.16 Million EUR	0.0%
2016 FY	-21.88 Million EUR	-28.69%
2016 Q4	-11.71 Million EUR	0.0%
2015 FY	-17 Million EUR	-77.92%
2015 Q4	-9.22 Million EUR	0.0%
2015 Q2	-7.77 Million EUR	0.0%
2014 FY	-9.55 Million EUR	-17.33%
2014 Q2	-4.16 Million EUR	0.0%
2014 Q4	-5.39 Million EUR	0.0%
2013 Q4	-3.86 Million EUR	0.0%
2013 Q2	-4.27 Million EUR	0.0%
2013 FY	-8.14 Million EUR	-52.79%
2012 Q3	-1.4 Million EUR	0.0%
2012 FY	-5.33 Million EUR	0.0%
2012 Q4	-1.4 Million EUR	0.0%

Peer Net Income Comparison of Nanobiotix S.A.

Name	Net Income	Net Income Difference
Boiron SA	35.82 Million EUR	210.81%
Laboratorios Farmaceuticos Rovi, S.A.	170.33 Million EUR	123.307%
Vetoquinol SA	55.56 Million EUR	171.454%
Valneva SE	-101.42 Million EUR	60.859%
AB Science S.A.	-10.04 Million EUR	-295.104%
PHAXIAM Therapeutics S.A.	-23.48 Million EUR	-69.022%
Vivoryon Therapeutics N.V.	-28.34 Million EUR	-40.075%
BioSenic S.A.	-28.77 Million EUR	-37.953%
ABIVAX Société Anonyme	-147.74 Million EUR	73.128%
Formycon AG	75.79 Million EUR	152.378%